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Abstract
Background: Urinary incontinence occurs in 40 % of women aged 65 years and over; however, only 15 % seek
care and many delay healthcare seeking for years. Incontinence is associated with depression, social isolation, reduced
quality of life, falls and other comorbidities. It is accompanied by an enormous cost to the individual and society.
Despite the substantial implications of urinary incontinence on social, psychological and physical well-being of older
women, the impact of continence promotion on urinary symptom improvement and subsequent effects on falls,
quality of life, stigma, social participation and the cost of care remains unknown.
Methods: This study is a mixed methods multi-national open-label 2-arm parallel cluster randomized controlled trial
aiming to recruit 1000 community-dwelling incontinent women aged 65 years and older across Quebec, Western
Canada, France and United Kingdom. Participants will be recruited through community organizations. Data will be
collected at 6 time points: baseline and 1 week, 3 months, 6 months, 9 months and 12 months after baseline. One of
the primary objectives is to evaluate whether the continence promotion intervention improves incontinence symptoms
(measured with the Patient Global Impression of Improvement questionnaire, PGI-I) at 12 months post intervention
compared to the control group. Other co-primary outcomes include changes in incontinence-related stigma,
fall reduction, and incremental cost-effectiveness ratio and quality-adjusted life years. Data analysis will account
for correlation of outcomes (clustering) within community organizations. A qualitative sub-study will explore
stigma reduction.
Discussion: Community-based continence promotion programs may be a cost-effective strategy to reduce
urinary incontinence, stigma and falls among older women with untreated incontinence, and simultaneously
improve quality of life and healthy active life expectancy.
Trial registration: ClinicalTrials.gov: NCT01858493, registered 13 May 2013
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Background
The “taboo” syndrome of urinary incontinence has
traditionally been stigmatized among older women des-
pite its remarkably high prevalence. In Canada, the
United Kingdom (UK) and France, almost 40 % of
women aged 65 years and older experience urinary in-
continence, but little more than 15 % seek care [1–4].
For many of these women, incontinence symbolizes a
decline into frailty and dependency [5]. Coping strat-
egies include the avoidance of social activities because
of the potential for embarrassment due to loss of
bladder control in public, resulting in a vicious cycle of
reduced participation, social isolation, depression and
loss of independent living [6]. Urinary incontinence has
consistently been associated with shame [6], poor
quality of life [6, 7], poor self-rated health [7], social
isolation [6], and depression [6, 8].
Incontinence is also linked to falls in older people, espe-
cially when leakage is associated with urgency and rushing
to the toilet in order to prevent leakage [9–14]. Urge in-
continence describes incontinence associated with feelings
of urgency, and has been shown to increase the risk of falls
by 50 % [9], with resultant fall-related injuries. The rela-
tionship between falls and urinary incontinence can be
explained by shared underlying pathophysiological mecha-
nisms, problems with dual-tasking and cortical inhibition,
and white matter hyperintensities [15–17]. Urinary incon-
tinence alone, and because of its association with falls, has
been associated with functional decline, nursing home ad-
mission and significant out-of-pocket expenses [18, 19].
This is a tragedy as incontinence is largely treatable, with
cures and improvements obtainable at all ages even with
conservative management [20].
Receipt of care for incontinence has been shown to
lead to measurable improvements in quality of life for
older adults [21]. Unfortunately, almost 85 % of incon-
tinent older women never talk to a healthcare practi-
tioner or seek help for their condition [4, 22–24].
Women who do not seek help may consider their in-
continence as not being serious enough, have inappro-
priate beliefs related to incontinence being a normal
part of aging, or may imagine that there is nothing that
can be done to treat it [24, 25].
To date, few public health initiatives have targeted
continence promotion, despite its substantial social, psy-
chological and physical ramifications for older adults.
Continence promotion involves challenging inappropri-
ate beliefs about incontinence, educating people that
evidence-based therapeutic options exist, and promoting
improvements and cures at all ages.
A pilot study compared the effectiveness of three experi-
mental continence promotion interventions against a
control intervention on urinary symptom improvement in
259 women aged 60 years and older with untreated
incontinence [26]. Participants were recruited from com-
munity organizations [27]. The highest rate of urinary
symptom improvement occurred among participants who
received a combined a 1-hour constructivist learning
workshop and a self-management program. Sixty-six per-
cent of participants in this group achieved improvement
in urinary symptoms, compared to 11 % of the control
group (prevalence difference 55 %, 95 % confidence
interval (CI) 43 –67 %, intracluster correlation 0). The
number-needed-to-treat was 2 to achieve any improve-
ment in incontinence symptoms, and 5 to attain sig-
nificant improvement. Changes in knowledge and self-
reported risk-reduction behaviors paralleled rates of
improvement [26].
The trial described in this protocol seeks to build on
the successful pilot study by testing whether the com-
bined continence promotion intervention can diminish
incontinence-related stigma and falls, and improve quality
of life in addition to reducing urinary symptoms in older
community-dwelling women with incontinence. This clus-
ter randomized controlled trial, conducted internationally
across the UK, France and Canada, will enable accrual of
a larger sample of culturally diverse women in whom to
test the continence promotion intervention. Prolonging
the follow-up period to 1 year, as compared to only
3 months in the pilot project, will allow us to see if the
benefits of the combined intervention can be maintained
and improved over 1 year. Further, this will permit time
for women to seek healthcare after they have tried some
self-management tools. The impact on fall reduction,
quality of life and healthy active life expectancy will also
be assessed.
Study hypothesis
We hypothesize that, compared to the control group, re-
ceipt of the combined continence promotion intervention
will result in a significant improvement in incontinence
symptoms in at least 20 % of women, a reduction in falls
of 30 %, an expected change of 4.74 points on the Incon-
tinence Quality of Life Scale (I-QOL) and a gain in utility
points on the 6 dimensional derivative of the 12-item
Short Form Health Survey (SF-6D) of 0.0126, with which
to calculate cost-effectiveness, cost-utility and gains in
healthy active life expectancy (Fig. 1).
Aim and study objectives
This study aims to evaluate the effectiveness of a con-
tinence promotion program on incontinence symptoms,
rate of falls, self-stigma and quality of life in community-
dwelling women with incontinence. In addition, the study
aims to evaluate the economic efficiency (incremental cost-
effectiveness and cost-utility) of providing community-
based group continence workshops to untreated older
women with incontinence.
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The objectives are to:
1. Evaluate whether the continence promotion
intervention yields significant improvement in
incontinence symptoms at 1 year post intervention
compared to the control group.
2. Examine the effects of a continence promotion
intervention on self-stigma among women with
untreated urinary incontinence.
3. Examine whether the receipt of a continence
promotion intervention leads to a reduction in falls
and fall-related injuries.
4. Investigate the effects on quality of life and ascertain
the cost-effectiveness/cost-utility of the continence




The Continence Across Continents To Upend Stigma
and Dependency (CACTUS-D) study is an open-label,
two-arm, parallel group, multi-national cluster ran-
domized controlled trial to be conducted across four
sites. A cluster design was deemed necessary to minimize
the chances of contamination between participants in
different arms of the trial. Individuals in a given commu-
nity often share information through discussion or direct
observation. We surmised that older women rarely migrate
to more than one community, hence we were confident
that community-level cluster randomization would
minimize the chances of contamination between the
two arms of the trial.
The two arms in this trial are the continence promo-
tion intervention arm and the sham control arm. Figure 2
shows the flow of participants through the study. A
qualitative study relating to stigmatization associated
with continence will be embedded in the trial with a
sub-group of participants. The qualitative sub-study will
be conducted across all four sites and will seek to under-
stand the effects of a continence promotion intervention
on self-stigma among women with untreated urinary
incontinence.
An economic evaluation will be conducted alongside
the trial to examine the difference in costs and outcomes
between the continence promotion intervention and
control groups. If the continence promotion interven-
tion is deemed effective in both cost saving and im-
provement in outcomes, then it is labeled dominant to
the comparator. An economic evaluation is useful for
decision-making in comparing the cost and outcomes.
Study participants and setting
Eligibility of community organizations
All community organizations in Quebec, Western Canada,
France and the UK will be eligible to participate and re-
cruit older community-dwelling women to the trial.
Eligibility of community-dwelling participants
Community-dwelling incontinent older women attending
workshops organized by participating community organi-
zations will be eligible to take part in the study. Women
eligible for inclusion will be those aged 65 years or older
who are able to communicate either in English or in
French. They will have had to experience urinary incon-
tinence with a frequency of two or more times per week,
and not sought professional advice for incontinence symp-
toms within the past year. Exclusion criteria are women
diagnosed with dementia.
Ethical approval
The ethics review boards of the Institut Universitaire de
Gériatrie de Montréal in Quebec, the University of
Fig. 1 Logic model for the Continence Across Continents To Upend Stigma and Dependency (CACTUS-D) trial
Tannenbaum et al. Trials  (2015) 16:565 Page 3 of 11
Brunel in the UK, the University of Poitiers in France,
and the University of Alberta in Alberta all approved the
study protocol by 26 March 2013 (ClinicalTrials.gov
identifier: NCT01858493). No personal identifiers will
be used in any reports or publications. Study procedures
and benefits will be explained to the enrolled women,
and written consent will be obtained for baseline
measurements.
Recruitment and application of eligibility criteria
Organizations
Recruitment will be via community organizations. Eli-
gible organizations will be contacted via post, tele-
phone or Email by a research assistant, and invited to
host an older women’s health workshop. Organizations
will be strategically selected by convenience sampling
and word of mouth to target older women. Previous
organizations from the pilot study [26, 27] for this
project will not be recruited. In order to be inclusive
of diversity, a conscious effort will be made to approach
culturally and socio-economically diverse groups of
women through outreach to different community organi-
zations in urban and rural areas from a wide area around
each study site. Once the organization has consented to
host a workshop and a local organizer has been selected
from the organization, a mutually convenient date will be
chosen for the local event. The event will be advertised via
telephone calls, word of mouth, and targeted advertise-
ments featured in online or paper newsletters, and mailed
invitations, printed by the organization inviting their
members to attend.
Participants
Following the recruitment of community organizations,
all women who decide to attend the workshops will be
self-identified for participation in the study. Recruitment
strategies vary slightly per site, based on the require-
ments of the respective ethics committees. In France
and in Western Canada, baseline data will be collected
and participants will be screened and enrolled to the
study prior to the receipt of the intervention. In the UK
and Quebec, women will complete the baseline ques-
tionnaire prior to the delivery of the intervention, but in-
terested participants will sign the consent form and
return the baseline questionnaire only after the work-
shop is completed. In a second screening stage, a re-
search assistant confirms eligibility status and interest in
enrolling in the trial via telephone follow-up within
1 week of the workshop.
Fig. 2 Study flow
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Across all sites, a subsample of participants will be re-
cruited for an ethnographic study that aims to explore
continence stigma, aging, and participant perspectives of
the intervention and control workshops. Data from the
qualitative interviews will help the team understand the
mechanisms and outcomes of the intervention on self-
stigma related to incontinence. Approximately 20 par-
ticipants will be interviewed within 2 weeks of the
workshop to explore participant perspectives of the
intervention and control workshops, and related feelings
associated with continence and age-related stigma. A
second group of 20 participants will be interviewed
1 year after the intervention workshop. Five partici-
pants from each trial site will be purposively selected
from those who have shown significant benefit from the
continence promotion intervention, to investigate the
impact on stigma and to understand the mechanisms
behind the perceived benefits of the workshop.
Randomization
Randomization/Concealment of allocation
Randomization will occur prior to delivery of the inter-
vention. The unit of randomization will be the commu-
nity organization. Using block randomization with an
alternating block size of 2 or 4, we will randomly allo-
cate clusters (via a 1:1 ratio and stratified by site) to the
intervention or control group via a computer-generated
random digit performed by an independent statistician
(Fig. 2). Stratification by site will aim to account for any
variation resulting from site characteristics and partici-
pants from individual community organizations. The
trial is, nonetheless, considered open-label because both
the research assistant who delivers the interventions and
the study participants who will have received the inter-
ventions will be aware of group allocation at the time of
implementation.
Blinding
The trial is blinded at the level of cluster randomization:
community organizations are aware that their partici-
pants will receive one of the two interventions, but they
will be blinded to group allocation. Participants will be
aware of which intervention they receive as the interven-
tion is open-label. A research assistant, who will be blinded
to group allocation, will inform, deliver and complete the
questionnaires after each telephone follow-up. A statisti-
cian blinded to the allocation will conduct the analysis and
reporting of the co-primary outcome measures.
Intervention
The continence promotion intervention is a single 45-
minute interactive group continence promotion program
delivered by a trained research assistant/workshop facilita-
tor. The continence intervention incorporates constructivist
learning and discusses the risk factors, causes and treat-
ments for incontinence and challenges the misconception
that incontinence is a normal part of aging. It aims to mo-
tivate community-dwelling women to initiate evidence-
based self-management and/or to consult for treatment
[26–30]. The intervention workshop is introduced as an
educational workshop addressing “taboo” topics related to
aging (memory problems and incontinence). Risk factors
and different etiologies for incontinence are reviewed,
physiology and pathology explained in lay terms and modi-
fiable strategies for risk reduction are recommended. A
paper-based self-management tool is provided at the end of
the workshop to help participants monitor their symp-
toms before and after attempting evidence-based self-
management strategies. This paper-based tool asks
women to identify one of the risk factors they may have
for urine leakage and to implement a strategy for risk
reduction. This is the same intervention that was tested
in the pilot trial [26].
The sham control intervention (the comparator) for
this study is a single 45-minute interactive group workshop
on other health topics of importance to older women. The
topics discussed are memory problems, medication inter-
actions, sleep problems, and hearing loss. Incontinence is
mentioned briefly during the sham control intervention in
order to integrate it with the questionnaire that revolves
around bladder problems.
A fidelity protocol and checklist for delivery of the inter-
vention will be applied every 6 months to each study site,
in order to ensure standardized implementation of the
intervention in each country.
Study follow-up
Study follow-up will include five telephone calls. The
first within a week of the workshop then at, 3, 6, 9 and
12 months post workshop. Telephone interviews normally
last from 5 to 40 minutes.
Outcomes
Improvement in urinary incontinence at 12 months
The co-primary outcome will be the participant’s global
impression of improvement in incontinence symptoms,
measured at 1-year post intervention by telephone inter-
view using the Patient’s Global Impression of Improve-
ment (PGI-I) questionnaire. The PGI-I is a validated,
single-item global rating of change scale that asks the
patient to describe how their incontinence condition is
now compared to how it was prior to the intervention
(very much better, much better, a little better, no change,
a little bit better, much worse and very much worse) [31].
Significant improvement will be defined as participants
rating their incontinence symptoms as much better or very
much better. This measure showed excellent acceptability,
known-group validity, reliability and responsiveness during
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the pilot study [26]. The PGI-I questionnaire will be ad-
ministered at 3 months, 6 months and 1 year post inter-
vention to all participants in all countries by the research
assistant at each site (Table 1).
Secondary outcomes such as self-reported rates of self-
management for treating urinary symptoms and/or seeking
professional help will be collected using identical methods
from our pilot study [26]. Further, to help determine the
process by which the intervention leads to significant im-
provement in incontinence, the International Consultation
on Incontinence-Female Lower Urinary Tract Symptoms
(ICIQ-FLUTS) questionnaire will measure the frequency,
severity and bother from incontinence [32]. The ICIQ-
FLUTS will be administered at baseline to screen partici-
pants for inclusion to the trial, and repeated at 6 months
and 12 months post intervention (Table 1). The ICIQ-
FLUTS diagnostic item will be used by participants to
describe the type of incontinence at baseline.
Stigma and quality of life
The second co-primary outcome will be the difference
in quality of life and stigmatization between the inter-
vention and control groups. The 22-item Incontinence
Quality of Life questionnaire (I-QOL) is a validated quality
of life instrument for urinary incontinence that includes
content relevant to stigma, such as “I worry about others
smelling urine on me” and “I worry about being embar-
rassed or humiliated because of my incontinence” [33].
Exploration of stigma perceptions will be supplemented
by the data collected in the qualitative interviews among a
sub-group of participants immediately after, and at 1 year
post intervention. Data will be collected using semi-
structured one-to-one interviews. The qualitative inves-
tigation will also be used in the development of the
Continence Psychosocial Impact of Assistive Devices
Scale (C-PIADS), which is being developed from the
original validated Psychosocial Impact of Assistive
Devices Scale (PIADS). PIADS is a 26-item self-report
questionnaire that includes 3 domains: competence
(reflecting perceived functional capability, independence
and performance); adaptability (reflecting inclination or
motivation to participate socially and take risks); and self-
esteem (reflecting self-confidence, self-esteem, and emo-
tional well-being). This team is developing a modified
version of this measure, C-PIADS that will evaluate the
impacts of continence care product use on psychosocial
constructs including perceived stigma [34, 35]. In addition
to the original 26 items, the present version of the C-
PIADS includes an additional 7 items, including self-
consciousness, fear of being “outed,”’ social acceptance,
secrecy, isolation, revealing to others, social participation
and intimate relations. The C-PIADS will be administered
on two occasions, after completion of the ethnographic
interview, and on the telephone 1 week after the ethno-
graphic interview.
Falls
The third co-primary outcome measure will be falls
experienced by women exposed to the continence inter-
vention compared to women exposed to the sham treat-
ment 1 year postintervention. Falls will be measured as
the group rate of falls at 12 months; the proportion of
women who had a fall; and the proportion of injurious
falls. Falls will be defined as an unexpected event in
which the person comes to rest on the ground, floor or
lower level [36]. Data for falls will be obtained from a
falls diary with telephone reminders [37]. Previous work
has shown that falls diaries pose significant advantage
over other methods of capturing falls among older-aged
people [37].
Incremental cost-effectiveness ratio and quality-adjusted
life years
We will conduct both cost-effectiveness and cost-utility
analysis (CEA and CUA) to explore and quantify the
cost per health (or utility) gain. The primary measure of
Table 1 Timeline of study assessment and data collection
Questionnaires Baseline 1 week 3 months 6 months 9 months 12 months
T0 T1 T2 T3 T4 T5









and end of study
PGI-I ✓ ✓ ✓ ✓
ICIQ-FLUTS ✓ ✓ ✓
I-QOL ✓ ✓ ✓
Falls Diary ✓ ✓ ✓ ✓ ✓
SF-12 ✓ ✓ ✓
Cost questionnaire ✓ ✓ ✓ ✓
ICIQ-FLUTS International Consultation on Incontinence-Female Lower Urinary Tract Symptoms, I-QOL Incontinence Quality of Life, PGI-I Patient’s Global Impression
of Improvement, SF-12 12-item Short Form Survey
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effectiveness for CEA will be presented as the incremental
cost-effectiveness ratio (ICER), defined as the additional
cost per participant achieving an improvement in urinary
incontinence over a 1-year period. The SF-6D measure of
health-related quality of life will be used to calculate utility
scores for the estimation of quality-adjusted life years
(QALYs) for the CUA. Derivation of the SF-6D is from
item responses on the SF-12 questionnaire, a generic
health- related quality of life measure, across 6 dimen-
sions: physical functioning, role limitations due to physical
health, bodily pain, vitality, social functioning, role limita-
tions due to emotional problems, and mental health [38].
The QALY is a measure of a participant’s life expectancy,
weighted by their health-related quality of life, valued on a
self-reported utility score, where a score of 1 reflects
perfect health and 0 is equivalent to dead [38]. The in-
cremental cost per QALY gained will be estimated at
1 year post intervention and will be depicted in a cost-
effectiveness analysis decision tree. The SF-12 question-
naire will be administered at baseline and at 6-months
and 12-months post intervention, while the cost ques-
tionnaires will be administered at 3-month, 6-month,
9-month and 1-year follow-up to the study participants
(Table 1).
Sample size
The sample size calculations were not equivalent for all
the co-primary outcomes of the study and, therefore,
differ based on the various outcomes.
We hypothesize that the sample size required to
demonstrate the effectiveness of the continence pro-
motion intervention will be sufficient as it is powered
to detect a minimally clinical important difference of
20 % in the proportion of participants globally rating
their improvement in urinary symptoms as “much better”
or “very much better,” with an expected change in the
control group of 6 % [39]. As the design is a cluster ran-
domized trial, we need to adjust for both the clustering
and the effect of unequal cluster sizes [40]. Based on the
results from the pilot study [26], an estimated average
cluster size of 4 participants and an intra-class correlation
coefficient (ICC) of 0.02, we would require a minimum of
14 community organizations per arm (a minimum of 56
participants per arm) to be able to detect a difference of
20 %, with 80 % power and alpha 0.05. To account for
attrition, which we estimate to be around 15 %, we de-
cided to set the recruitment target to at least 100 partici-
pants per arm.
The sample size needed for the falls outcome antici-
pates an average baseline fall rate per group of 30 %
[26], and hypothesizes that the intervention will have an
effect on the incidence rate of falls of 0.21 (30 % relative
reduction). A minimum sample size of 388 per group (at
least 97 community organizations per group) is needed
to detect this minimally important difference with 80 %
power, 5 % level of significance, an ICC of 0.02 and an
average cluster size of 4.
Sample size for the economic analysis was calculated
using a mapping exercise to convert a minimally important
difference on the I-QOL to the SF-12 to account for the
possibility that the SF-12, a generic quality of life measure,
may be insufficiently sensitive to reflect important dif-
ferences in incontinence-related quality of life [39]. An
improvement of 6.65 points on the I-QOL scale best
matched an improvement (as much better or very much
better) on the PGI-I, which we defined as a minimally im-
portant difference. Then, using a Monte Carlo simulation,
we calculated that using this change cut-off, a detectable
difference of 4.74 on the I-QOL between the intervention
and control groups, would be statistically significant
(at 0.05 alpha level) in at least 80 % of simulations
when each group comprises at least 500 participants,
representing a gain of 0.0126 in SF-6D utility scores.
Taking into account the sample size calculation for all
co-primary outcome measures, we therefore aim to re-
cruit the participants according to the largest sample size
that will be sufficient for sub-group analyses (n = 500 par-
ticipants per group) – a total of 1000 participants.
Data analysis
Co-primary outcomes
Differences in baseline characteristics between the groups
will be determined using descriptive statistics (means,
proportions), to assess any imbalance in potential con-
founders. All analyses will be done on an intention-to-
treat basis. To assess improvements in incontinence, we
will estimate the unadjusted risk difference (prevalence of
the outcome) and 95 % confidence interval (CI) via
generalized estimating equations (GEEs) with an iden-
tity link and an exchangeable correlation structure to
account for possible correlation between women in the
same organization [41]. The effects of various potential
confounders in the groups at baseline will be explored
because of the possibility for selection bias in an open
trial. To adjust for imbalance in potential confounders,
additional analyses will be conducted using multivariate
logistic regression estimated via GEE with an exchange-
able correlation structure. As a sensitivity analysis, we
will repeat the analysis on a per protocol basis that will
include participants who adhered to the protocol and
follow-ups.
Incontinence-specific quality of life will be assessed using
the Incontinence Quality of Life Instrument (I-QOL). The
22 items in the I-QOL will be summed and then trans-
formed to a 0 to 100 scale for greater interpretability, with
the higher scores representing greater quality of life.
The I-QOL subscales (avoidance or limiting behaviors,
psychological impacts, social life impact, and social
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embarrassment) will be scored in an identical manner. In
an ad hoc analysis, crude effect sizes, examining change in
scale scores at each assessment within participant group
(intervention and control), will be calculated and
evaluated using Cohen’s d criteria (i.e., 0.2–0.49 is small,
0.5–0.79 is moderate, and 0.8 and above is large). Multi-
variate linear models will be used to compare each I-QOL
subscales score reported by the intervention group to the
control group, with the control group as the referent and
participants clustered by organization. Age at baseline and
other potential confounders will be included as covariates
in all adjusted models.
Fall rates in the intervention and the control groups
will be analyzed as follow: (1) the incidence rate of falls,
using Poisson regression to allow for clustering of falls
by the same participant, (2) the proportion of patients
who had one or more falls versus no falls, using logistic
regression analyses, and (3) the proportion of injurious
falls, using logistic regression analyses. Each analysis
will use patient-level data that will be clustered by
organization and analyzed via GEE with an exchangeable
correlation structure and a log and a logit link for Poisson
and logistic regression analyses respectively. Negative
binomial regression will be used to model the incidence
rate of falls, if there is evidence of over-dispersion of
the data using Poisson regression. Multivariate analyses
will adjust for any confounding variables that may
affect the relationship between incontinence and falls.
Analysis of the qualitative sub-study on stigma
The interview data on stigma will be analyzed using the
principles of content description. The goal of content
analysis is to generate a group of concepts that describes
primary research questions. All text that addresses the
fundamental research questions will be coded, whereby
relevant text will be assigned a “heading” in the margin
of the transcript. Headings will be reviewed, and categories
of headings created. In the final step of content analysis, in-
vestigators will identify meaningful patterns within and
across interview transcripts, and prepare general descrip-
tors of the data. For this step, we will upload the data into
ATLAS-ti, a software program designed to aid in the ana-
lysis of large bodies of text.
Economic analysis
In this analysis we will assess the cost of the continence
promotion program for senior women with incontinence
compared to the sham control group. The study will in-
volve constructing a decision analytic model through
which we will estimate the cost-effectiveness and cost-
utility of the intervention. This will take the form of a
decision tree and will be based directly on the preva-
lence for the global rating of improvement (as “much
better” or “very much better”) in urinary incontinence as
the outcome (Fig. 3). Each of the branches in the deci-
sion tree represents a set of actions or strategies under
assessment and will be populated with data on probability,
costs and utilities obtained from data collection in the
study. The decision tree remains identical for every option
in the model, although probabilities change.
Data and parameter estimates specific to Canada will
be used to calculate the ICERs, first from a societal
perspective and then from a healthcare system perspec-
tive. ICERs for the healthcare system perspective as base
case will be of interest to site-specific health policy makers
for resource allocation decisions, should the continence
Fig. 3 Decision tree model for the cost-effectiveness analysis. Legend: decision-tree model for the cost-effectiveness analysis. The square indicates
group randomization; the circles indicate chance nodes; the triangles indicate terminal nodes
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promotion intervention be found effective. Critically, the
ICER from a societal perspective will facilitate discourse
on the full opportunity cost of individual pad use in the
context of the selected site. The results of the CEA will be
expressed as cost per percentage improvement in the
prevalence of urinary incontinence as measured by PGI-I
and the results of the CUA will be expressed as cost per
QALY gained. The ICER from the CEA will be compar-
able with other continence intervention programs using
the same outcome measure (improvement in urinary in-
continence), while QALYs from the CUA is a more stan-
dardized measure (not specific to the outcome measure)
and will be comparable more broadly.
A probabilistic sensitivity analysis will be undertaken
using the uncertainty estimates, in which the key model’s
parameters will be replaced with plausible values drawn
from specified probability distribution assigned to those
parameters. Uncertainty surrounding the cost-effectiveness
and cost-utility results will be provided by plotting rep-
lications on the cost-effectiveness and cost-utility plane
and reviewed in cost-effectiveness and cost-utility ac-
ceptability curves.
Discussion
This study aims to evaluate the impact of a continence
promotion intervention on community-dwelling older
women with untreated incontinence. Previous research
suggests that an intervention combining constructivist
learning and an evidence-based self-management tool is
effective in reducing urinary symptoms. [26] The current
study will investigate whether the benefits of this con-
tinence promotion intervention extend to a reduction
in falls and stigma, improvements in quality of life and
social participation, and gains in healthy active life ex-
pectancy. Generalizability to different cultural settings
will be achieved by testing the intervention across three
countries in both English and French to determine its
effect on multiple co-primary outcomes.
Strengths
The strengths of this study include the robust randomized
controlled trial design with baseline and long-term
follow-up, the quantitative and qualitative mixed ana-
lysis and the use of multiple measures as primary out-
comes. Additionally, the international platform for this
study will facilitate rapid accrual of sample size and ex-
ternal validity at minimum cost, while meeting the
needs of regulatory agencies in different jurisdictions.
The synergies enabled by the intervention have the po-
tential to produce a paradigm shift in attitudes toward
incontinence in older women, and among health pro-
fessionals empowered to address multimorbidity in an
aging population. Although incontinence has been as-
sociated with falls, to date no trial exists that causally
links reductions in falls to exposure to a continence
promotion intervention that improves urinary symp-
toms. Furthermore, this is the first trial to assess the
impact of incontinence symptom improvement, fall re-
duction and quality of life on QALYs and healthy active
life expectancy in older women.
Limitations
There are a few limitations to our study. Many of our out-
come measures are by self-report, though supplemented
with objectively measured data whenever possible. We
attempted to use a bladder diary to measure improve-
ments in incontinence during our pilot study [26] in the
UK, however, a large proportion of unreliable or missing
data was collected. Further, for incontinence severity of
less than once every 2 days, the responsiveness of this
measure is poor [42]. We acknowledge the possibility of
recall bias for the baseline measures and importantly, the
diary falls entry. However, we tried to limit this bias by
implementing telephone follow-up reminders.
Post-randomization recruitment bias is also a possi-
bility for participants who have not been screened for
incontinence prior to randomization of the clusters [27].
Knowledge translation
Knowledge translation is assured as our recruitment
strategies reach out directly to community organizations
and their constituents. The results of this study will be
communicated to community stakeholders and the general
public as an incontinence awareness initiative. Our ultimate
goal will be to contribute to discussions around public
health social policy change to support a more proactive so-
ciety-wide management of incontinence. The progress
of the study, interim and final results will be presented
at relevant national or international conferences. Man-
uscripts will be submitted for publication in peer-
reviewed journals. The aim is to make the intervention
accessible in a train-the-trainers format to community
organizations and primary care institutions after com-
pletion of the study.
Potential impact
Incontinence increases with age and is strongly associated
with reduced self-esteem, social isolation, depression, and
a higher likelihood of dependency and institutionalization.
The current lack of social policies and public health initia-
tives surrounding community-based continence promo-
tion strategies offers a fertile ground on which to build
this study and a stepping stone for developing continence
expertise in other related settings such as hospitals and
long-term care. Despite the high prevalence of incon-
tinence in seniors, there is a surprising lack of evidence-
based public health campaigns to improve continence
among older women and to reduce the stigma, negative
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beliefs and loss of functional independence associated
with incontinence.
This study will use a novel constructivist group inter-
vention combined with innovative evidence-based self-
management tools for older community-dwelling women
with incontinence, with the aim of increasing disability-
free lifespan and quality of life. The economic analysis
will determine the costs incurred by the continence pro-
motion intervention and facilitate a realistic budget
impact assessment that can be used to supplement sus-
tainable interventions for healthy aging.
Evidence linking continence promotion to fall reduction
and improvements in healthy active life expectancy will
inform future public policy and fall prevention programs.
Trial status
The trial is currently recruiting participants and is ap-
proximately 60 % complete at the time of submission.
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